Earnings Feed
Start Free
Home/Filings/4/0000313143-12-000089
4//SEC Filing

FORISH JOSEPH J 4

Accession 0000313143-12-000089

CIK 0000313143other
View on SEC.govCompany Profile

Filed

Jun 20, 8:00 PM ET

Accepted

Jun 21, 5:05 PM ET

Size

21.2 KB

Accession

0000313143-12-000089

Insider Transaction Report

Form 4
Period: 2012-06-20
HAEMONETICS CORPHAE
FORISH JOSEPH J
VP, Human Resources
Transactions
  • Sale

    Common Stock

    2012-06-20$72.23/sh−13,000$939,030→ 8,497 total
  • Exercise/Conversion

    Common Stock

    2012-06-20$48.20/sh+11,000$530,145→ 19,497 total
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2012-06-20$72.23/sh−13,000$939,030→ 23,000 total
    Exercise: $48.20From: 2006-12-19Exp: 2012-12-19→ Common Stock (13,000 underlying)
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2012-06-20$72.40/sh−11,000$796,375→ 12,000 total
    Exercise: $48.20From: 2006-12-19Exp: 2012-12-19→ Common Stock (11,000 underlying)
  • Exercise/Conversion

    Common Stock

    2012-06-20$48.20/sh+13,000$626,535→ 21,497 total
  • Sale

    Common Stock

    2012-06-20$72.40/sh−11,000$796,375→ 8,497 total
Holdings

  • Non-Qualified Stock Option (right to buy)

    Exercise: $51.07From: 2008-10-24Exp: 2014-10-24→ Common Stock (11,799 underlying)
    11,799

  • Non-Qualified Stock Option (right to buy)

    Exercise: $52.94From: 2010-10-27Exp: 2016-10-27→ Common Stock (14,690 underlying)
    14,690

  • Non-Qualified Stock Option (right to buy)

    Exercise: $54.99From: 2011-10-27Exp: 2017-10-27→ Common Stock (15,388 underlying)
    15,388

  • Non-Qualified Stock Option (right to buy)

    Exercise: $61.34From: 2012-10-25Exp: 2018-10-25→ Common Stock (15,370 underlying)
    15,370

  • Non-Qualified Stock Option (right to buy)

    Exercise: $52.76From: 2007-05-05Exp: 2013-05-05→ Common Stock (10,373 underlying)
    10,373

  • Non-Qualified Stock Option (right to buy)

    Exercise: $54.55From: 2009-10-22Exp: 2015-10-22→ Common Stock (11,911 underlying)
    11,911
Footnotes (3)
  • [F1]Pursuant to a 10b5-1 Plan.
  • [F2]Total includes Restricted Stock Awards and/or Restricted Stock Units that are subject to restrictions until vesting requirements are met. Grant was made under 2005 Long Term Incentive Compensation Plan.
  • [F3]Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.

Documents

1 file

Issuer

HAEMONETICS CORP

CIK 0000313143

→
Entity typeother

Related Parties

1
  • filerCIK 0001240941

Filing Metadata

Form type
4
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 5:05 PM ET
Size
21.2 KB
View on SEC.gov